- Report
- January 2026
- 180 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 188 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 186 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- March 2025
- 175 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- February 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- January 2026
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- April 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- July 2024
- 100 Pages
Global
From €3284EUR$3,750USD£2,851GBP
- Report
- March 2023
- 185 Pages
Global
From €3897EUR$4,450USD£3,383GBP
Carbon-11 is a radioactive isotope of carbon used in Nuclear Medicine and Radiopharmacology. It is produced in a cyclotron and is used in the production of radiopharmaceuticals, which are used in medical imaging and therapy. Carbon-11 has a short half-life of 20.4 minutes, making it ideal for use in PET scans and other imaging techniques. It is also used in the production of targeted radiopharmaceuticals, which are used to treat cancer and other diseases.
The Carbon-11 market is a rapidly growing sector of the radiopharmaceuticals industry. It is used in a variety of medical applications, including PET scans, targeted radiopharmaceuticals, and other imaging techniques. Companies in the Carbon-11 market include GE Healthcare, Mallinckrodt Pharmaceuticals, and Bracco Diagnostics. Show Less Read more